19th International Conference on Cytochrome P450 (ICCP450 Tokyo 2015)

Presentation information

Print

Session

[Session 12] P450s and Drug Design

Sun. Jun 14, 2015 4:20 PM - 6:20 PM Hall B (1st Meeting Room 2F)

Chair:Toshiyuki Sakaki (Department of Biotechnology, Toyama Prefectural University)

[Session 12-4] CYP24A1 is a key enzyme to develop vitamin D analogs as anti-osteoporosis or anti-cancer drugs

○Toshiyuki Sakaki 1, Kaori Yasuda 1, Shinichi Ikushiro 1, Keiko Yamamoto 2, Tai C. Chen 3, Atsushi Kittaka 4 (1.Department of Biotechnology, Toyama Prefectural University, 3.Laboratory of Drug Design and Medicinal Chemistry, Showa Pharmaceutical University, 5.School of Medicine, Boston University)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.
You can find the password on the inside front cover of the program book.

Password